Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-11 6:54 pm Sale | 13G | ANIKA THERAPEUTICS INC ANIK | Avidity Partners Management LP | 0 0% | -731,000 (Position Closed) | View |
| 2022-02-11 6:31 pm Purchase | 13G | ADICET BIO INC ACET | Avidity Partners Management LP | 3,034,004 7.9% | 1,174,004 (+63.12%) | View |
| 2022-02-11 6:24 pm Purchase | 13G | SEASPINE HLDGS CORP COM SPNE | Avidity Partners Management LP | 2,010,000 5.5% | 2,010,000 (New Position) | View |
| 2022-02-11 6:16 pm Purchase | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | Avidity Partners Management LP | 1,896,000 6% | 1,896,000 (New Position) | View |
| 2022-02-11 6:07 pm Purchase | 13G | CYTEIR THERAPEUTICS INC CYT | Avidity Partners Management LP | 1,849,538 5.2% | 1,849,538 (New Position) | View |
| 2022-02-01 3:33 pm Purchase | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | Avidity Partners Management LP | 3,022,790 6.7% | 3,022,790 (New Position) | View |
| 2022-01-03 12:09 pm Purchase | 13G | KEZAR LIFE SCIENCES INC KZR | Avidity Partners Management LP | 3,228,200 6.6% | 3,228,200 (New Position) | View |
| 2022-01-03 12:07 pm Purchase | 13G | ALTIMMUNE INC ALT | Avidity Partners Management LP | 2,765,000 7% | 2,765,000 (New Position) | View |
| 2021-12-01 11:04 am Purchase | 13G | IDEAYA BIOSCIENCES INC IDYA | Avidity Partners Management LP | 2,470,179 6.4% | 2,470,179 (New Position) | View |
| 2021-10-27 6:12 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Avidity Partners Management LP | 1,120,925 6.6% | 1,120,925 (New Position) | View |
| 2021-10-25 10:36 am Purchase | 13G | IVERIC BIO INC ISEE | Avidity Partners Management LP | 7,225,000 7% | 7,225,000 (New Position) | View |
| 2021-04-20 4:34 pm Purchase | 13G | SYNDAX PHARMACEUTICALS INC SNDX | Avidity Partners Management LP | 4,750,000 9.9% | 1,442,000 (+43.59%) | View |
| 2021-03-22 4:05 pm Purchase | 13G | PHASEBIO PHARMACEUTICALS INC C PHAS | Avidity Partners Management LP | 4,285,000 9.4% | 4,285,000 (New Position) | View |
| 2021-02-16 4:46 pm Purchase | 13G | ALPINE IMMUNE SCIENCES INC ALPN | Avidity Partners Management LP | 1,470,390 6.2% | 132,977 (+9.94%) | View |
| 2021-02-16 12:01 pm Purchase | 13G | ANIKA THERAPEUTICS INC ANIK | Avidity Partners Management LP | 731,000 5.1% | 731,000 (New Position) | View |
| 2021-02-16 11:43 am Purchase | 13G | SCYNEXIS INC SCYX | Avidity Partners Management LP | 1,979,800 9.9% | 882,546 (+80.43%) | View |
| 2021-02-16 11:38 am Purchase | 13G | ONCOSEC MED INC PAR $0.000 ONCS | Avidity Partners Management LP | 1,952,000 5.5% | 262,000 (+15.50%) | View |
| 2021-02-16 11:32 am Purchase | 13G | SYNDAX PHARMACEUTICALS INC SNDX | Avidity Partners Management LP | 3,308,000 7.1% | 708,000 (+27.23%) | View |
| 2021-02-16 11:26 am Purchase | 13G | KADMON HLDGS LLC COM KDMN | Avidity Partners Management LP | 9,570,000 5.6% | 9,570,000 (New Position) | View |
| 2021-02-12 11:17 am Purchase | 13G | ADICET BIO INC ACET | Avidity Partners Management LP | 1,860,000 9.5% | 1,860,000 (New Position) | View |